Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04838119 · ClinicalTrials.gov registry record
Preop COVID Testing Patterns
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 375,692
- Enrollment target
NCT04838119: Completed study, sponsored by Wake Forest University Health Sciences.
NCT04838119 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 375,692 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04838119 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 375,692 participants
- Enrollment target
Study Summary
This study is an investigation of preoperative asymptomatic COVID screening nationwide. The hypothesis is that because these tests are performed without reference to pretest probability of COVID-19 disease, unlike tests based on symptoms or close contact with infected individuals, these studies may represent a more unbiased sample of the local population prevalence of asymptomatic COVID disease burden.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375,692 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2021-08-23 |
What the finished NCT04838119 record still lists
NCT04838119 is an observational study that tracks outcomes without assigning an intervention. Its 375,692 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04838119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04838119 about?
NCT04838119 is a clinical study titled "Preop COVID Testing Patterns". This study is an investigation of preoperative asymptomatic COVID screening nationwide. The hypothesis is that because these tests are performed without reference to pretest probability of COVID-19 disease, unlike tests based on symptoms or close contact with infected individuals, these studies may ...
What is the current status of trial NCT04838119?
This trial is currently completed. The enrollment target is 375,692 participants. The study started on 2021-04-01. Estimated completion is 2021-08-23.
Who is sponsoring clinical trial NCT04838119?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06934239 · 400,000 participants · Phase 4
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
- NCT06342375 · 425,000 participants · NA
Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI